Ken Griffin Generation Bio Co. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$2.64 - $4.35 $20,592 - $33,930	-7,800 Reduced 98.73%	100 $0
Q1 2024 May 15, 2024	BUY	$1.73 - $4.07 $8,477 - $19,943	4,900 Added 163.33%	7,900 $32,000
Q4 2023 Feb 14, 2024	BUY	$0.91 - $3.35 $1,092 - $4,020	1,200 Added 66.67%	3,000 $4,000
Q3 2023 Nov 14, 2023	BUY	$3.65 - $6.9 $2,920 - $5,520	800 Added 80.0%	1,800 $6,000
Q2 2023 Aug 14, 2023	SELL	$3.5 - $5.67 $32,550 - $52,731	-9,300 Reduced 90.29%	1,000 $5,000
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $36,461 - $70,801	10,100 Added 5050.0%	10,300 $44,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $732 - $1,354	200 New	200 $0

50M

100

200

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $169M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.